0001179110-18-010751.txt : 20180822
0001179110-18-010751.hdr.sgml : 20180822
20180822071825
ACCESSION NUMBER: 0001179110-18-010751
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180817
FILED AS OF DATE: 20180822
DATE AS OF CHANGE: 20180822
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NEWTON ROGER S
CENTRAL INDEX KEY: 0001242612
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35986
FILM NUMBER: 181031412
MAIL ADDRESS:
STREET 1: 3621 SOUTH STATE ST
STREET 2: 695 KMS PL
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Esperion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001434868
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3891 RANCHERO DRIVE, SUITE 150
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
BUSINESS PHONE: 734-887-3903
MAIL ADDRESS:
STREET 1: 3891 RANCHERO DRIVE, SUITE 150
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
FORMER COMPANY:
FORMER CONFORMED NAME: HDL THERAPEUTICS INC
DATE OF NAME CHANGE: 20080513
4
1
edgar.xml
FORM 4 -
X0306
4
2018-08-17
0
0001434868
Esperion Therapeutics, Inc.
ESPR
0001242612
NEWTON ROGER S
C/O ESPERION THERAPEUTICS INC.
3891 RANCHERO DRIVE, SUITE 150
ANN ARBOR
MI
48108
1
0
0
0
Common Stock
2018-08-17
4
S
0
7300
50.06
D
616426
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 21, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.48, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4
/s/ Richard B. Bartram, by power of attorney
2018-08-21